OBJECTIVES: The objective of adjunctive drug utilization pattern is to know the proportion of adjunctive drugs used in cancer inpatient’s , to improve the quality of health care, for proper planning of indenting and budgeting of adjunctive drugs in Oncology (Radiotherapy) Department. METHODS: The study was conducted in the Oncology (Radiotherapy) Department of Guntur Medical College and Government General Hospital, Guntur. The study method includes prioritizing the patients based on inclusion and exclusion criteria.  Information regarding drug utilization is collected with the aid of a data collection form from the inpatient’s case sheets. The collected data will be tabulated and analyzed using suitable statistical tools. RESULTS: The most commonly observed cancer type was cervix ( 26.54%) followed by Head and Neck ( 23.9%). In our study, we observed that there is more prevlence(80%) of gynaecological cancers in women. There was female predominance (67%) in cancer prevalence.  The present study shows maximum number of patients are between the age group of 40- 60 years (33.6%). The total drugs used in inpatient oncology department are 70450, among all the drugs 16015 are parenteral formulations, whereas 54435 are oral formulations. Ondansetron is the mostly used drug (17.5%) followed by diclofenac (12.7%) and ranitidine (12.5%). The drugs use for prevention of chemotherapy induced adverse drug reactions include mesna (100%), Potassium sulfate (100%), Magnesium sulfate (100%) and Ondansetron (70%).  In our study total cost of drugs (300974.4 rupees), in total cost Ondansetron has 14.7% and least was amlodipine of 0.018%.  CONCLUSIONS:

There are 32 adjunctive drugs used in inpatient oncology department.   The drug utilization study we conducted helped to know the prescribing and usage pattern of drugs in inpatient radiotherapy department, there by the indenting of drugs is very easy without any drug lackage. The cost considerations are helped for proper budget preparation.